V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1) Polyclonal Antibody
CAU21405
ApplicationsImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
Product group Antibodies
TargetMYCL
Overview
- SupplierBiomatik
- Product NameV-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1) Polyclonal Antibody
- Delivery Days Customer12
- ApplicationsImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
- Applications SupplierWB; IHC; ICC; IP.
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.5 mg/ml
- ConjugateUnconjugated
- Gene ID4610
- Target nameMYCL
- Target descriptionMYCL proto-oncogene, bHLH transcription factor
- Target synonymsL-Myc, LMYC, MYCL1, bHLHe38, protein L-Myc, class E basic helix-loop-helix protein 38, l-myc-1 proto-oncogene, myc-related gene from lung cancer, protein L-Myc-1, v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog, v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived
- HostRabbit
- Protein IDB4DJH2
- Protein NameProtein L-Myc
- Scientific DescriptionThe V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
- Reactivity SupplierHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203





